Momenta Pharmaceuticals, Inc. (MNTA)

[tinkershaw]

Good point. Clearly Sandoz is not going to want to give away those copaxone revenues, just because it might be worth billions of dollars in marketcap for MNTA.

Which, of course, it should also be worth to MNTA if/when they do get copaxone approved and on the market. Clearly a significant chink in any merger discussion. Probably a fatal one.

Tinker